Gan shinten katei no genomu toransukuriputōmu kaiseki by アオト, ヨシマサ et al.
  
 
Genome and transcriptome analysis for 
the process of cancer progression 
 
 
 
 
 
 
 
 
 
 
November 2018 
 
 
Yoshimasa Aoto 
 
YâĊ 
  (3) 
 G é  ã  No.1     
nfºa ¸ H Î      a « d Ā ßë 
 
GéĂdċ 
 Genome and transcriptome analysis for the process of cancer progression 
 Ć
-ózõÊ17;@5=?20>95A;æ¡ć 
 
 
ĆSwãć 
 

-Qój,#E¹F)G¨i 1Â'*)ĉï~Ã
Ì&(Ĉ
-óz%CmBý¤	Âä
'*BĈ
-ÑÛ
¾¶	'ßÝ½Ĉ^ĈíÈ©þ¿ózõÊ]¿µæCì
)ĉéĈ
-óz</63;]¿µæ,À¿ĈÝ½õÊ
ý)17;@5=?20>95A;æ¡,áĉ 
17;æ¡ÃÌÝ½õÊÓ¿ð&(Ĉ
-ó^õÊæ¡,áĉ
":.2,·¾
-vĄ,Z·Ĉ¼oùLBù,pÇ¿_)c
BPM¶bÝ½,[eðĈbÝ½Óo^æ¡& Ý½üªîæ¡
,áĉ*&(ĈÒ¿íÈ)ÞÝ½Ć^ÐWćñ×®r
Ý½Ćñ×ÐWćĈ**»)o»,³@Õ)
Åh*ĉ
"Ĉo»àËõÊ,æ¡)Ĉ^ÐWß÷k*)B
Ĉñ×ÐWÝ½¾¶X	'÷k*(ĈÝ½ôgā}
	'V{)`Ü
Åh*ĉ 
§ĈÆÝ½õÊ5=?20>95A;æ¡,áĉ17;æ¡17;o
»ÖØ¿æ¡
`Ü)BĈ5=?20>95A;æ¡RøJså¥øJs¾´
uúĈ&  Iüªîæ¡
`Ü)ĉ´l"¤	5=?20>95A;æ¡¬

£*)BĈÃÌyê)©þ¿
-ózõÊ&Ĉq{°)vĄ I
,æ¡¬ÄÍ*ĉ"Ĉq I,¾´|»øJsæ¡¬,å
û¾)ĉèOvĄ&(Ĉ£¬t0=24Vă¬ª!ā}ą
ÏøJs0=24,U`Ü)
Å*ĉ'Ĉ£¬,¾
-v
Ą&(Ó¿'*Ý½ö·)Ĉ
-ózõÊ¾´o\,Å
øJsÙ,160=24Văĉ*0=24$**²u¶M¦Üý+)øJ
sÙ
Tÿ(Ĉb0=24
-ózõÊ²¿¾´84A?,øJsÙ
,âç)ĉ 
éĈ17;æ¡5=?20>95A;æ¡,òĈ
-óz)Ý½Só^
õÊ%Ĉ
-^K¾´o\,Å²¿øJsÙ­x,D
ĉ
-ózõÊbõÊ,Á¿æ¡NÉ(Ĉ±ÃÌÔ¢
Ú¯Ĉ"Ĉ&Á¿æ¡ã,Å
ĉ 
 
    
 
                                    Keio University 
 
Thesis Abstract 
 No.    1    
Registration 
Number 
□ “KOU”   □ “OTSU” 
No.        *Office use only 
Name Yoshimasa Aoto 
Thesis Title 
 Genome and transcriptome analysis for the process of cancer progression 
 
 
Thesis Summary 
Cancer is known as one of the leading causes of death in the world. Recent years have witnessed substantial 
progress in understanding tumor heterogeneity and the process of tumor progression; however, the entire 
step-wise process of the transition of tumors from benign to metastatic state remains poorly understood. In this 
dissertation, I conducted genome- and transcriptome-sequencing analyses for the tumorigenesis process to reveal 
the entire mechanisms of the tumor progression. 
In the genome-sequencing study, I performed a prospective analysis by employing an experimental 
carcinogenesis mouse model to systematically understand the evolutionary process of tumors. I surgically 
collected a part of a lesion of each tumor and followed the passage of these tumors over time. Comparative 
time-series analysis of the genomes of tumors with different fates, i.e., those that eventually metastasized and 
regressed, suggested that these tumors acquired and inherited different mutations. Despite the occurrence of an 
intra-tumor selection event for malignant alteration during the transformation from early- to late-stage papilloma, 
the fate determination of tumors might be determined at an even earlier stage. 
While the genome-sequencing enables us to analyze the genomic mutations, transcriptome-sequencing 
technology is widely used to comprehensively detect and quantify cellular gene expression. Numerous analytical 
methods have been proposed for identifying differentially expressed genes (DEGs) between paired samples such 
as tumor and control specimens, but few studies have reported methods for analyzing differential expression 
under multiple conditions as my research target, the step-wise process of the tumor progression. In the 
transcriptome-sequencing study, I propose a novel method, DEclust, for differential expression analysis among 
more than two matched samples from distinct tissues or conditions. As compared to conventional clustering 
methods, DEclust more accurately extracts statistically significant gene clusters from multi-conditional 
transcriptome data. As a result of applying my method to the cancer transcriptome analysis, DEclust extracted 16 
gene clusters whose expression patterns were discriminative in the process of the tumor progression; moreover, 
the genes which were belonging to each of these clusters were significantly enriched for biological functions. 
Through the genome and transcriptome studies, I gave insights of the evolutional process in the tumors over time 
and the gene clusters whose expression patterns were discriminative in the process of the tumor progression. An 
example of the research that directly analyzes the process of tumor progression is rare; hence, my results are 
meaningful and I consider that it is necessary to advance such a direct approach to reveal the entire process of 
cancer progression. 
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